Formokem Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 47 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -48.28%
(FY 2023)
- Profit -93.10%
(FY 2023)
- Ebitda -99.59%
(FY 2023)
- Net Worth 2.95%
(FY 2023)
- Total Assets 0.82%
(FY 2023)
About Formokem Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Madhusudan Maheshwari, Santkumar Kedarnath, Piyush Maheshwari, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24110MH1977PTC019554
- Company No.
019554
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Mar 1977
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Formokem Chemicals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhusudan Maheshwari  | Director | 15-Mar-1977 | Current |
| Santkumar Kedarnath | Director | 01-Dec-2001 | Current |
| Piyush Maheshwari | Director | 01-Jan-2023 | Current |
| Rakesh Lakhotia | Director | 01-Jan-2023 | Current |
| Navnitkumar Mahesh | Director | 17-Jan-2020 | Current |
Financial Performance and Corporate Structure Insights of Formokem Chemicals.
Formokem Chemicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.28% decrease. The company also saw a substantial fall in profitability, with a 93.1% decrease in profit. The company's net worth moved up by a moderate rise of 2.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Formokem Chemicals?
In 2023, Formokem Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vedant Dyestuffs Intermediates Private LimitedActive 31 years 4 monthsPiyush Maheshwari is a mutual person
Azatrius Pharmaceuticals Private LimitedActive 19 years 2 monthsPiyush Maheshwari is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Formokem Chemicals?
Formokem Chemicals has a workforce of 49 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Formokem Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Formokem Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
